ASSET MANAGEMENT CORP /IL/ /ADV – CRISPR Therapeutics AG Transaction History
ASSET MANAGEMENT CORP /IL/ /ADV portfolio value:
$229,000
portfolio value
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 53K | $65.35 | 11.63K | |
| Q3 2022 | call | Decrease | -20.45% | -900 shares | -38K | $65.35 | 3.5K |
| Q2 2022 | call | 0.00% | 0 shares | -9K | $60.77 | 4.4K | |
| Q2 2022 | share | Decrease | -6.44% | -800 shares | -73K | $60.77 | 11.63K |
| Q1 2022 | call | Decrease | -74.86% | -13.1K shares | -1.05M | $62.77 | 4.4K |
| Q1 2022 | share | Increase | +12.34% | 1.36K shares | -59K | $62.77 | 12.43K |
| Q4 2021 | call | Decrease | -2.78% | -500 shares | -689K | $78.85 | 17.5K |
| Q4 2021 | share | Increase | +2.67% | 288 shares | -367K | $78.85 | 11.06K |
| Q3 2021 | call | Increase | 0.00% | 18K shares | 2.01M | $111.93 | 18K |
| Q3 2021 | share | Increase | +11.68% | 1.12K shares | -356K | $111.93 | 10.77K |
| Q2 2021 | share | Decrease | -11.63% | -1.27K shares | 231K | $161.89 | 9.65K |
| Q1 2021 | share | Increase | +270.17% | 7.97K shares | 741K | $121.85 | 10.92K |
| Q4 2020 | share | 0.00% | 0 shares | 343K | $153.11 | 2.95K | |
| Q3 2020 | share | Increase | 0.00% | 2.95K shares | 247K | $83.64 | 2.95K |